loading page

His-Purkinje System Pacing Upgrade Improve the Heart Performances in Patients Suffering from Pacing-induced Cardiomyopathy with or without Permanent Atrial Fibrillation
  • +6
  • Yiheng Yang,
  • kexin wang,
  • peipei Ma,
  • rongfeng zhang,
  • Bin Waleed Khalid,
  • Xiaomeng Yin,
  • Lianjun Gao,
  • Yunlong Xia,
  • yingxue Dong
Yiheng Yang
First Affiliated Hospital of Dalian Medical University
Author Profile
kexin wang
First Affiliated Hospital of Dalian Medical University
Author Profile
peipei Ma
First Affiliated Hospital of Dalian Medical University
Author Profile
rongfeng zhang
First Affiliated Hospital of Dalian Medical University
Author Profile
Bin Waleed Khalid
First Affiliated Hospital of Dalian Medical University
Author Profile
Xiaomeng Yin
First Affiliated Hospital of Dalian Medical University
Author Profile
Lianjun Gao
First Affiliated Hospital of Dalian Medical University
Author Profile
Yunlong Xia
First Affiliated Hospital of Dalian Medical University
Author Profile
yingxue Dong
First Affiliated Hospital of Dalian Medical University
Author Profile

Abstract

The efficacy and safety of His bundle pacing (HBP) and left bundle branch pacing (LBBP) upgrades in patients with pacing-induced cardiomyopathy (PICM) and atrial fibrillation (AF) are still unknown. Methods and results Patients with PICM were continuous enrolled from January 2018 to March 2020. All patients were further divided into AF subgroup and sinus rhythm subgroup. Clinical data including echocardiographic examination parameters, electrocardiogram (ECG) measurements, and New York Heart Association (NYHA) classification, were assessed before and after a his-purkinje system pacing (HPSP) upgrade. The HBP and LBBP upgrades were completed in 34 of 36 (94%), Complications including electrode dislodged, perforation, infection or thrombosis were not observed in perioperative period. During a mean of 11.52±5.40 months of follow-up. The left ventricular ejection fraction (LVEF) increased significantly (33.76±7.54 vs 40.41±9.06, P<0.001), and the QRS duration decreased (184.22±23.76ms vs 120.52±16.67ms, P<0.001) after the HBP upgrades. LVEDD reversed from 59.29±7.74 mm to 53.91±5.92 mm (P<0.001), and the NYHA functional class also improved to 2.00±0.76 from 2.55±0.91 at the first follow-up (P<0.001). The left atrium (LA) size also slightly decreased compared to the initial state (59.29±7.74mm VS 56.44±6.46, P=0.005). The threshold o did not increase significantly (1.18±0.76 mv@0.4ms vs 1.26±0.91mv @ 0.4ms, P=0.581). These improvements in patients with AF were similar with those in patients without AF (P >0.05). Conclusion HBP and LBBP upgrades improved the heart performance and reversed the left ventricular remodeling in patients suffering from PICM with or without AF, and it should be a promising choice in these patients.

Peer review status:Published

Jul 2021Published in International Journal of Cardiology volume 335 on pages 47-51. 10.1016/j.ijcard.2021.04.012